Village Farms International, Inc., announced that starting later this month it will increase its global presence by beginning to ship cannabis products to the Israeli medical market.
On January 3rd, 2023, Village Farms International, Inc. announced it will begin to ship cannabis products through its subsidiary, Pure Sunfarms, to Israel’s medical cannabis market as part of an exclusive three-year supply agreement with Dr. Samuelov Importing and Marketing Ltd., doing business as Better Pharma (1).
According to the press release (1), the company also commented that the lack of cannabis legislative action by the United States Senate does not impact Village Farms' plans to leverage its success in Canada into other cannabis markets with greater regulatory support. The company currently sells products in Canada and Australia, and plans to enter the German medical market.
"Commencing shipments to Israel is another milestone in our global cannabis strategy, building on our successes in Canada and Australia," said Michael DeGiglio, Chief Executive Officer, Village Farms (1). "We are proud and privileged to partner exclusively with Better Pharma for the significant medical cannabis opportunity in Israel and are confident that Pure Sunfarms’ unique ‘Everyday Premium’ positioning, which has proven so successful in Canada and Australia, will be differentiated in the Israeli market, and well-received by patients."
"Our agreement with Better Pharma marks the first time Pure Sunfarms branded flower, inclusive of Canada's top-selling Pink Kush, makes its way to consumers internationally," said Mandesh Dosanjh, President and CEO, Pure Sunfarms (1).
"We are proud and honoured to exclusively partner with Pure Sunfarms, Canada's Number 1 flower brand and market leader, for medical cannabis products," said Ran Samuelov, Chief Executive Officer, Better Pharma (1). "We are confident we will be able to leverage our knowledge and expertise in international brand management for Pure Sunfarms to become one of the leading medical cannabis brands in Israel.”
According to information in the press release (1), Better Pharma imports, markets, and distributes international brands to the Israeli pharmaceutical market. In 2020, the company established the Cannabinoids unit, specializing in importing and distribution and marketing of medical grade cannabis product to the Israeli medical market.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.